An evaluation of 6 placebo-controlled scientific trials with one,134 full contributors concluded that cannabinoids (nabiximols, dronabinol, and THC/CBD) ended up related to a bigger normal improvement on the Ashworth scale for spasticity in numerous sclerosis sufferers in comparison with placebo, Even though this did not achieve statistical importa